Privia Health releases transcript of 2Q 2026 conference call
PRVA•2Q 2026 earnings call highlights
- Privia Health held its 2Q 2026 earnings call with CEO Parth Mehrotra, CFO David Mountcastle, and SVP Robert Borchert.
- 2Q practice collections rose 12.4% to $970 million; adjusted EBITDA gained 29% to $37.4 million, or 28.3% of care margin.
- Implemented providers reached 5,644 at June 30, up 10.1% year over year; attributed lives rose 19.2% to 1.64 million.
- Management raised its 2026 outlook across key metrics; attributed lives are now above the prior guidance high end, while implemented provider guidance was unchanged.
- Cash exceeded $412 million with no debt; 70%-80% of full-year adjusted EBITDA is expected to convert to free cash flow.
